HC Wainwright & Co. Reiterates Buy on Entera Bio, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a 'Buy' rating on Entera Bio (NASDAQ:ENTX) and maintained a $10 price target.
September 11, 2023 | 10:32 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Entera Bio's stock rating has been reiterated as 'Buy' by HC Wainwright & Co. with a maintained price target of $10.
The reiteration of the 'Buy' rating and maintained price target by HC Wainwright & Co. indicates their continued confidence in Entera Bio. This could potentially attract more investors, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100